C12N 2500/92
Medium free of human- or animal-derived components
C12N2500/92 (Medium free of human- or animal-derived components) appears on 70 US grants and 138 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 138
- Assignees
- 91
- Inventors
- 244
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 2 |
| 2004 | 1 | 2 |
| 2005 | 0 | 2 |
| 2006 | 0 | 3 |
| 2007 | 0 | 2 |
| 2008 | 0 | 10 |
| 2009 | 0 | 6 |
| 2010 | 1 | 7 |
| 2011 | 5 | 8 |
| 2012 | 3 | 10 |
| 2013 | 3 | 6 |
| 2014 | 4 | 3 |
| 2015 | 5 | 11 |
| 2016 | 6 | 11 |
| 2017 | 9 | 7 |
| 2018 | 5 | 7 |
| 2019 | 4 | 7 |
| 2020 | 3 | 1 |
| 2021 | 8 | 6 |
| 2022 | 1 | 10 |
| 2023 | 1 | 8 |
| 2024 | 2 | 6 |
| 2025 | 5 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Generation of pancreatic progenitor cells and beta cells from human pluripotent stem cells6 Jan 2026US 12,516,295 B2The Penn State Research Foundation
- Single cells pluripotent stem cells in a suspension culture23 Dec 2025US 12,503,684 B2Technion Research & Development Foundation Limited
- Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state9 Dec 2025US 12,492,371 B2Technion Research & Development Foundation Limited
- Serum-free medium for avian vaccine production and uses thereof14 Oct 2025US 12,441,989 B2Boehringer Ingelheim Vetmedica GmbH
- Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state16 Sep 2025US 12,415,985 B2Technion Research & Development Foundation Limited
- Production and therapeutic use of off-the-shelf double negative t cells24 Jul 2025US 2025/0235482 A1University Health Network
- Method for preparing a comestible nutrient composition and use thereof6 Mar 2025US 2025/0072441 A1The Cultivated B. GmbH
- Method for further upscaling the large-scale production of the oncolytic h-1 protoparvovirus (h-1pv) using a carrier-based production process combined with an optimized cell culture medium6 Feb 2025US 2025/0043251 A1
- Production processes for highly viable, engraftable human chondrocytes from stem cells22 Aug 2024US 2024/0279608 A1University of Southern California
- Methods of producing rpe cells11 Jul 2024US 2024/0228955 A9Biolamina AB
Most cited
By later US patents
- Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell40US 6,825,036 B2Juridical Foundation The Chemo-Sero-Therapeutic Research Institute · 2004
- Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using33US 6,103,526 AProtein Sciences Corporation · 2000
- Edible and animal-product-free microcarriers for engineered meat28US 9,752,122 B2Modern Meadow, Inc. · 2017
- Process for the culturing of cells24US 8,440,458 B2Dsm IP Assets B.V. · 2013
- Methods for making recombinant proteins using apoptosis inhibitors19US 6,586,206 B1Genentech, Inc. · 2003